20.04.2015 • NewsDede WillamsHuntsmancapacity expansion

Huntsman Increases Specialty Amine Capacity

US chemical producer Huntsman has announced plans to expand capacity for specialty amines at its sites in Petfurdo, Hungary, and Conroe, Texas, US, by 2016. Financial investment and capacity were not disclosed.

The company said its new multipurpose unit at Petfurdo will add to its manufacturing portfolio, further leverage its integrated amines capability and increase existing specialty amine production capacity at the Hungarian facility by 20%.

At the Texas plant, Huntsman will add equivalent capacity and improve the flexibility of its specialty amine unit.

Over the past several years Huntsman, which claims to be the world's leading manufacturer of specialty amines, said it "has seen interest in many specialty amine product lines accelerate from users in the polyurethane foams, coatings, lubricants and detergents across the globe."

Stu Monteith, president of Huntsman's Performance Products division, said the capacity expansion leverages the company's strong manufacturing and technology base and enhances what he said is already the widest in-house manufacturing capability across the industry.

The US chemical producer said it has "consistently improved capability and extended the product range manufactured at Petfurdo over the past 15 years, adding that "the new capacities show the commitment that we will build ahead of the demand curve to match our customers' growth."

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.